Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.9 USD | -0.93% | +21.08% | +164.26% |
05-07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
05-06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+164.26% | 724M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M